Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Palo Alto Networks

    Protecting Pharma from cyber attacks and systems misuse helping to ensure IP Protection and availability in manufacturing environments

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    - PMLiVE

    Genetic Digital

    We guide healthcare and life sciences organisations through digital transformation. Simplifying the complex world of tech and marketing, we create impactful assets and strategies to drive long-term growth and positive…

    View Profile

    Creative and design, Digital communications, IT solutions, Marketing consultancies, Medical communications

    - PMLiVE

    Nmblr

    From day-one concept to launch and beyond, Nmblr is the strategy and collaboration platform that partners with biopharma teams.

    View Profile

    IT solutions

    Company Details

    Palo Alto Networks
    4401 Great America Parkway, Santa Clara, CA, 95054, USA
    Contact Palo Alto Networks
    Website

     Latest Content from PMHub 

    Top 5 tips for a multi-indication product launch

    White Papers and Resources | July 20, 2020 | Blue Latitude Health

    Senior Associate Consultant Sana Rahim and Senior Consultant Victoria Clark explain the lessons the team has learned from launching six different indications of an oncology product in an accelerated timeframe.

    National Educational Webcast on Virtual Care: a Customer Story

    White Papers and Resources | July 17, 2020 | Impetus Digital

    Learn how our client used Impetus Digital's virtual tools and services to develop and execute a national educational webinar on telehealth.

    If our patients are diverse, why are clinical trials so white?

    White Papers and Resources | July 17, 2020 | Blue Latitude Health

    Despite facing worse health outcomes, minority populations are often left out of clinical trials and miss the opportunity to participate in life-saving research. Associate Consultant Ling Song explores this issue...

    Havas Lynx Group elevates Jon Chapman and Paul Kinsella to CCOs

    Press Releases | July 17, 2020 | Havas Lynx

    Havas Lynx Group announces the promotion of Jon Chapman and Paul Kinsella from Executive Creative Directors (ECD) to Chief Creative Officers (CCO) for Havas Lynx Group.

    Bedrock Group strengthens its senior team

    Press Releases | July 17, 2020 | Bedrock Healthcare Communications

    Bedrock Healthcare Communications have strengthened its senior management team

    Article: Pricing a coronavirus vaccine

    White Papers and Resources | July 17, 2020 | Inizio

    Using findings from Research Partnership's recent COVID-19 impact study, Market Access Directors Rachel Howard and Brett Gardiner and Consultant Suzan Serip explore the challenges of pricing a coronavirus vaccine. Read...

    News: Living with Ulcerative Colitis and Crohn’s Disease

    White Papers and Resources | July 17, 2020 | Inizio

    Living with Ulcerative Colitis (UC) and Crohn’s Disease (CD) are new patient syndicated reports which offer valuable insights into patient attitudes and behaviour towards their condition, treatments and unmet needs. These reports...

    Forging innovative solutions by merging art and science

    Videos and Podcasts | July 16, 2020 | Impetus Digital

    In the latest episode of Impetus Digital's Fireside Chat, we dive into the concept of merging art and science with Ariel Garten, Founder & Chief Evangelism Officer at Muse. Ariel...

    Session 3: Systems Innovation Examples and Process

    Videos and Podcasts | July 16, 2020 | Impetus Digital

    In this session, we discussed the processes involved in systems innovation and reviewed a few examples. We examined the transformational changes that can evolve over time when we go beyond...

    PoTS LIVE: A unique ethnography study in rare disease

    Press Releases | July 15, 2020 | Bedrock Healthcare Communications

    Digital ethnography has been deployed with PoTS patients for the first time, by Origins Insights, with significant results for the PoTS UK charity.